Suchergebnisse - "Henry, Linda"

PubPharm (411)

51

The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease : Data from National Health and nutrition examination survey 2005-2010 and 2017-2018

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Younossi, Z. | Paik, J. | Golabi, P. | +3

52

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States

enthalten in: JAMA network open | 2022

von Nguyen, V. | Kam, L. | Yeo, Y. | +4

53

Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world : Data from the global liver registry

enthalten in: Journal of viral hepatitis | 2022

von Younossi, Z. | Yu, M. | El-Kassas, M. | +21

54

Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection

enthalten in: Hepatology communications | 2022

von Younossi, Z. | Stepanova, M. | Lam, B. | +16

55

MAFLD and Pregnancy : What are the Consequences?

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Nakanishi, A. | Henry, L. | Nguyen, M.

CommentOn: Clin Gastroenterol Hepatol. 2022 Nov;20(11):2542-2550.e8. - PMID 34798335

56

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Henry, L. | Paik, J. | Younossi, Z.

57

Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Younossi, Z. | Paik, J. | Al Shabeeb, R. | +3

CommentIn: Hepatology. 2022 Nov;76(5):1243-1245. - PMID 35503710

58

Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection

enthalten in: Scientific reports | 2022

von Park, H. | Lo-Ciganic, W. | Huang, J. | +5

59

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

enthalten in: Clinical and molecular hepatology | 2022

von Le, M. | Yeo, Y. | Zou, B. | +4

60

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World : Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Younossi, Z. | Yilmaz, Y. | Yu, M. | +29